Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Articles 10 YÖKSİS 10 · OpenAlex 0 Total citations 456 h-index 14 · OpenAlex Q1 articles 0 Scopus · WoS Q1 1 Co-authors 49 2 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 8 + YÖKSİS · co-author record: 50
h-index 14 Percentile in Türkiye: 67 #575 of 1,472 at their university by h-index
i10-index
17
Total citations
456
Top 42% in Türkiye
Per article
7.9
FWCI
0.72
1.00 = world average
World top 1%
0
World top 10%
3
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 50 articles (385 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list. h-index on the OpenAlex author profile: 13.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
49
With an akaturk profile
7
Turkish institutions
2
Co-authored works
%90

Academic co-authors 7

  1. ERTUĞRUL BAYRAM Doçent · Çukurova Üniversitesi same university 3
  2. MELEK ERGİN Profesör · Çukurova Üniversitesi same university 3
  3. HASAN ÇAĞRI YILDIRIM Doçent · Ege Üniversitesi 2
  4. BURAK METE Doçent · Çukurova Üniversitesi same university 1
  5. NEBİ SERKAN DEMİRCİ Profesör · İstanbul Üniversitesi-Cerrahpaşa 1
  6. TOLGA KÖŞECİ Doçent · Çukurova Üniversitesi same university 1
  7. TUĞBA TOYRAN Doktor Öğretim Üyesi · Çukurova Üniversitesi same university 1

National collaboration 2 institutions

Within own university5 joint works · Çukurova Üniversitesi

  1. Ege Üniversitesi 2 works · 1 academics
  2. İstanbul Üniversitesi-Cerrahpaşa 1 works · 1 academics

Other co-authors (incl. international) 42

Afsar Cigdem Usul 3Duman Berna Bozkurt 3Gunaldi Meral 3Kara Oguz 3Erdoğan Şeyda 2Erçolak Vehbi 2Paydas Semra 2Sahin Berksoy 2Avci ArbilAydin MehmetAçıkalın ArbilBARIŞ KÖKSALBuyukdereli GulgunDisel UmutDuman BBErkisi I. Melek KoksalErkisi MelekGonlusen GulfilizKara BKelle Aygul PolatKibar MustafaMEHMET ALİ KAZĞIMEHMET MUTLU KIDIMURAD GULIYEVMUSTAFA SEYYARPERVİN CAN ŞANCIParsak CKReyhan MehmetSEDAT BİTERSakman GSertdemir YasarTUGAY AVCIUnal IlkerYASEMİN AYDINALP CAMADANYapar A. FuatYapar ZeynepYavuz Sinancaner kaperelvin chalabiyevhalil göksel güzel

Show all (42)

perihan perkinŞENDAĞ YASLIKAYA

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 2 articles
OpenAlex citation percentile
Top 1%0
Top 10%0
Avg · n 8 %74.2
Other counts

Scopus (SJR)

  • YÖKSİS rows 8

WoS (JCR)

  • YÖKSİS rows 8

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

10articles

Journals with publications

8 journals

Narrow down

Scopus (SJR)
Q10 Q24 Q33 Q41
WoS (JCR)
TR Index

Article list

  1. 2024 can the pathological response in patients with locally advanced gastric cancer receiving neoadjuvant treatment be predicted by the CEA/albumin and CRP/albumin ratios? Journal of Clinical Medicine Research-Canada DOI 10.3390/jcm13102984 YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.9%
  2. 2024 comparision ofthe efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma Journal of chemotherapy DOI 10.1080/1120009X.2024.2403051 YÖKSİS SJR Q3 JCR Q3 OpenAlex 78.7%
  3. 2024 Exploring the Impact of Cytogenetic Abnormalities on Treatment Responses and Survival Outcomes in Multiple Myeloma: A Single-Centre Experience of 13 Years of Follow-Up Biomedicines DOI 10.3390/biomedicines12051014 YÖKSİS SJR Q2 JCR Q1 OpenAlex 55.3%
  4. 2024 Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study Journal of Chemotherapy DOI 10.1080/1120009X.2024.2330835 YÖKSİS SJR Q3 JCR Q3 OpenAlex 87.7%
  5. 2024 Kronik Lenfositik Lösemi/ Küçük Lenfositik Lenfoma Tedavi Yaklaşımları Türkiye Klinikleri Sağlık Bilimleri Dergisi YÖKSİS TR Index
  6. 2014 A New Approach to the Treatment of Metastatic Paraganglioma Sorafenib Cancer Research and Treatment DOI 10.4143/crt.2013.093 YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.1%
  7. 2014 Bilateral Primary Adrenal Non Hodgkin Lymphoma Turkish Journal of Hematology DOI 10.4274/tjh.2013.0195 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 75.1%
  8. 2012 Analysis of PTEN VEGF HER2 and P53 status in determining colorectal cancer benefit from bevacizumab therapy Asian Pacific journal of cancer prevention : APJCP YÖKSİS
  9. 2012 Retrospective Analysis of 498 Primary Soft Tissue Sarcomas in a Single Turkish Centre Asian Pacific Journal of Cancer Prevention DOI 10.7314/APJCP.2012.13.8.4125 YÖKSİS SJR Q3 JCR Q4 OpenAlex 77.9%
  10. 2010 The value of 18F fluorodeoxyglucose positron emission tomography computed tomography in carcinoma of an unknown primary diagnosis and follow up Nuclear Medicine Communications DOI 10.1097/MNM.0b013e328332b340 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.6%

← Back to academicians